These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8195835)

  • 41. Glucoprotamin antimicrobial activity against selected standard antibiotic-resistant bacteria and reference strains used in the assessment of disinfection efficacy.
    Chojecka A; Wiercińska O; Röhm-Rodowald E; Kanclerski K; Jakimiak B
    Rocz Panstw Zakl Hig; 2015; 66(3):281-8. PubMed ID: 26400126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of thienamycin.
    Shah PM
    Methods Find Exp Clin Pharmacol; 1981; 3(6):387-90. PubMed ID: 7329164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial profile of flurithromycin, a new macrolide.
    Saverino D; Debbia EA; Pesce A; Lepore AM; Schito GC
    J Antimicrob Chemother; 1992 Sep; 30(3):261-72. PubMed ID: 1452490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the existence of synergism between different antibiotics and a phenothiazine tranquilizer, promazine, possessing antimicrobial property.
    Dastidar SG; Chakraborty P; Mookerjee M; Ganguly M; Chakrabarty AN
    Acta Microbiol Immunol Hung; 1994; 41(1):41-9. PubMed ID: 7921850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
    Locher HH; Schlunegger H; Hartman PG; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1376-81. PubMed ID: 8726004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
    Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
    Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
    J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.
    Loza E; Martínez Beltrán J; Baquero F; León A; Cantón R; Garijo B
    Eur J Clin Microbiol Infect Dis; 1992 Sep; 11(9):856-66. PubMed ID: 1468430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postantibiotic effect of the penem FCE 22101 against selected gram-positive and gram-negative bacteria in vitro and in vivo by the use of a tissue cage model in rabbits.
    Bergholm AM; Dornbusch K
    APMIS; 1990 Mar; 98(3):269-75. PubMed ID: 2317348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cefpodoxime proxetil in upper respiratory tract infections.
    Bergogne-Berezin E
    Drugs; 1991; 42 Suppl 3():25-33. PubMed ID: 1726205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
    Karthein J; Spohr M; Traub WH
    Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Spectrum of Thiazolidinediones against Respiratory Tract Pathogenic Bacteria: An In Vitro and In Silico Approach.
    Al Bratty M; Hakami AQ; Masmali HA; Alam MS; Alhazmi HA; Thangavel N; Najmi A; Moni SS; Haque A
    Curr Pharm Biotechnol; 2020; 21(14):1457-1469. PubMed ID: 32552647
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolates.
    Huovinen P; Wolfson JS; Hooper DC
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):255-7. PubMed ID: 1597204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
    Richards RM; Xing JZ
    J Antimicrob Chemother; 1996 Jul; 38(1):27-37. PubMed ID: 8858454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Antibacterial activity of vapors of protoanemonine].
    Didry N; Dubreuil L; Pinkas M
    Pharmazie; 1991 Jul; 46(7):546-7. PubMed ID: 1784621
    [No Abstract]   [Full Text] [Related]  

  • 57. Trimethoprim-resistant bacteria: cross-resistance patterns.
    Grey D; Hamilton-Miller JM
    Microbios; 1977; 19(75):45-54. PubMed ID: 567736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimum bactericidal concentration of sulfamethoxazole-trimethoprim for Haemophilus influenzae: correlation with prophylaxis.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):731-6. PubMed ID: 310281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bactericidal effect of ultraviolet C (UVC), direct and filtered through transparent plastic, on gram-positive cocci: an in vitro study.
    Rao BK; Kumar P; Rao S; Gurung B
    Ostomy Wound Manage; 2011 Jul; 57(7):46-52. PubMed ID: 21904015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.